Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Sales: 2011-2025

Historic Return on Sales for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 0.01%.

  • Aytu Biopharma's Return on Sales rose 7.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 7.00%. This contributed to the annual value of 0.01% for FY2025, which is 6.00% up from last year.
  • Aytu Biopharma's Return on Sales amounted to 0.01% in FY2025, which was up 118.32% from 0.05% recorded in FY2024.
  • Aytu Biopharma's 5-year Return on Sales high stood at 0.01% for FY2025, and its period low was 1.13% during FY2022.
  • Its 3-year average for Return on Sales is 0.07%, with a median of 0.05% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by 40bps in 2021, then skyrocketed by 97bps in 2023.
  • MRY analysis of 5 years shows Aytu Biopharma's Return on Sales stood at 0.89% in 2021, then fell by 27bps to 1.13% in 2022, then surged by 86bps to 0.16% in 2023, then skyrocketed by 68bps to 0.05% in 2024, then skyrocketed by 118bps to 0.01% in 2025.
  • Its Return on Sales stands at 0.01% for FY2025, versus 0.05% for FY2024 and 0.16% for FY2023.